Editorial: New progress in cancer biomarkers and therapy

Guohui Sun; Chengwei He; Jianhua Wang

doi:10.3389/fmolb.2024.1388872

Editorial: New progress in cancer biomarkers and therapy

Front Mol Biosci. 2024 Mar 7:11:1388872. doi: 10.3389/fmolb.2024.1388872. eCollection 2024.

Authors

Guohui Sun¹, Chengwei He², Jianhua Wang³

Affiliations

¹ Beijing Key Laboratory of Environmental and Viral Oncology, College of Chemistry and Life Science, Beijing University of Technology, Beijing, China.
² State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, China.
³ Beijing Municipal Key Laboratory of Child Development and Nutriomics, Capital Institute of Pediatrics, Beijing, China.

No abstract available

Keywords: bioinformatics; biomarkers; cancer; tumor microenvironment; tumor prognosis; tumor resistance; tumor therapy.

Publication types

Editorial

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work received the support from the Beijing Natural Science Foundation (No. 7242193, 7222016), the National Natural Science Foundation of China (No. 82003599), the Project of Cultivation for young top-motch Talents of Beijing Municipal Institutions (No. BPHR202203016) and the Science and Technology General Project of Beijing Municipal Education Commission (No. KM202110005005).